Evaluation of chylomicron effect on ASP production in 3T3-L1 adipocytes

Acta Biochimica et Biophysica Sinica

Volumn 43, Issue 2, 2011, Pages 154-159

  Gao, Ying ^a,b   Gauvreau, Danny ^a   Cui, Wei ^a   Lapointe, Marc ^a   Paglialunga, Sabina ^a   Cianflone, Katherine ^a  

^a LAVAL UNIVERSITY   (Canada)

^b First Affiliated Hospital   (China)

Author keywords

3T3 L1 adipocytes model; ASP production; ELISA assay

Indexed keywords

ACYLATION STIMULATING PROTEIN, MOUSE; CHYLOMICRON; COMPLEMENT COMPONENT C3; INSULIN; SIGNAL PEPTIDE;

ADIPOCYTE; ANIMAL; ARTICLE; BIOSYNTHESIS; CELL LINE; CELL STRAIN 3T3; DRUG EFFECT; METABOLISM; MOUSE; SECRETION;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELL LINE; CHYLOMICRONS; COMPLEMENT C3; INSULIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE;

ACCIPITRIDAE; MUS;

EID: 79551523396     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmq124     Document Type: Article

References (17)

1. Cianflone K, Xia Z and Chen LY. Critical review of acylation-stimulating protein physiology in humans and rodents. Biochim Biophys Acta 2003, 1609: 127-143.
2. Baldo A, Sniderman AD, St-Luce S, Avramoglu RK, Maslowska M, Hoang B and Monge JC, et al. The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis. J Clin Invest 1993, 92: 1543-1547.
3. Maslowska M, Sniderman AD, Germinario R and Cianflone K. ASP stimulates glucose transport in cultured human adipocytes. Int J Obes Rel Metab Dis 1997, 21: 261-266.
4. Yasruel Z, Cianflone K, Sniderman AD, Rosenbloom M, Walsh M and Rodriguez MA. Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue. Lipids 1991, 26: 495-499.
5. Desfaits AC, Serri O and Renier G. Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment. Diabetes Care 1998, 21: 487-493.
6. Havel RJ, Eder HA and Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955, 34: 1345-1353.
7. Scantlebury T, Sniderman AD and Cianflone K. Regulation by retinoic acid of acylation-stimulating protein and complement C3 in human adipocytes. Biochem J 2001, 356: 445-452.
8. Cianflone K, Sniderman AD, Walsh MJ, Vu H, Gagnon J and Rodriguez MA. Purification and characterization of acylation stimulating protein. J Biol Chem 1989, 264: 426-430.
9. Kalant D, Cain SA, Maslowska M, Sniderman AD, Cianflone K and Monk PN. The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein. J Biol Chem 2003, 278: 11123-11129.
10. Xia Z, Sniderman AD and Cianflone K. Acylation-stimulating protein (ASP) deficiency induces obesity resistance and increased energy expenditure in ob/ob mice. J Biol Chem 2002, 277: 45874-45879.
11. Ahren B, Havel PJ, Pacini G and Cianflone K. Acylation stimulating protein stimulates insulin secretion. Int J Obes Relat Metab Disord 2003, 27: 1037-1043.
12. Scantlebury T, Maslowska M and Cianflone K. Chylomicron-specific enhancement of acylation stimulating protein and precursor protein C3 production in differentiated human adipocytes. J Biol Chem 1998, 273: 20903-20909.
13. Maslowska M, Scantlebury T, Germinario R and Cianflone K. Acute in vitro production of acylation stimulating protein in differentiated human adipocytes. J Lipid Res 1997, 38: 21-31.
14. Cianflone K, Maslowska M and Sniderman AD. Acylation stimulating protein (ASP), an adipocyte autocrine: new directions. Semin Cell Dev Biol 1999, 10: 31-41.
15. Kalant D, Maslowska M, Scantlebury T, Wang H and Cianflone K. Control of lipogenesis in adipose tissue and the role of acylation stimulating protein. Can J Diabetes 2003, 27: 154-171.
16. Tahiri Y, Karpe F, Tan GD and Cianflone K. Rosiglitazone decreases postprandial production of acylation stimulating protein in type 2 diabetics. Nutr Metab 2007, 4: 11.
17. Oktenli C, Ozgurtas T, Dede M, Sanisoglu YS, Yenen MC, Yesilova Z and Kenar L, et al. Metformin decreases circulating acylation-stimulating protein levels in polycystic ovary syndrome. Gynecol Endocrinol 2007, 23: 710-717.